LLY Jan 2025 195.000 put
| Previous Close | 0.2500 |
| Open | 0.2500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 195.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.2500 - 0.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksEli Lilly (LLY) Advances But Underperforms Market: Key Facts
Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
- Reuters
Eli Lilly to acquire manufacturing facility from Nexus Pharma
Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines. Lilly expects production at the facility based in Pleasant Prairie, Wisconsin, to begin at the end of 2025. Soaring demand for GLP-1 agonists, a class of highly effective diabetes and obesity drugs which suppress appetite and promote a feeling of fullness, has led to constrained supply for drugmakers such as Lilly and Danish drugmaker Novo Nordisk .
Insider Monkey10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
